About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Clinical Trials (37)
View allTotal Trials
37
As Lead Sponsor
26
As Collaborator
11
Total Enrollment
4,482
By Phase
NA: 18PHASE3: 8PHASE4: 4PHASE1/PHASE2: 3
By Status
COMPLETED: 18TERMINATED: 8UNKNOWN: 7WITHDRAWN: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline37 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06618612Lead Sponsor
A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers
NARecruiting
170 participants
Started: Aug 19, 2024 · Completed: Nov 19, 2026
NCT06000410Lead Sponsor
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
PHASE3Active, not recruiting
474 participants
Started: Sep 6, 2023 · Completed: Nov 30, 2025
NCT04901013Lead Sponsor
Clinical Study Of Affinity Versus SOC In The Management Of VLUs
NAUnknown
200 participants
Started: Jun 14, 2021 · Completed: Jun 30, 2023
NCT04636229Lead Sponsor
Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
PHASE3Completed
516 participants
Started: Dec 14, 2020 · Completed: Aug 19, 2025
NCT03855514Lead Sponsor
Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers
NAUnknown
200 participants
Started: Feb 8, 2019 · Completed: Dec 30, 2021
Locations (1)
Headquarters
Canton, MA, United States
Map
Loading map...